FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

ANDA Approval Withdrawal Notice Corrected

[ Price : $8.95]

Federal Register notice: FDA corrects a notice in the 6/25 Federal Register that announced the approval withdrawal of 36 ANDAs fro...

Info Collection on Compounding Outsourcing Facilities

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Obtaining Information to Understand Ch...

Info Collection on User Fee Payment Forms

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension entitled Electronic User Fee Payment Request Forms ...

3 Drug Firms Pay $447 Million Over Price Fixing

[ Price : $8.95]

Generic drug makers Taro Pharmaceuticals, Sandoz and Apotex agree to pay $447 million to resolve alleged False Claims Act violatio...

De Novo Rule Clarifies Device Inspections

[ Price : $8.95]

A new FDA final rule on the medical device de novo marketing pathway clarifies earlier language contained in the proposed rule to ...

OMB Approves 23 FDA Information Collections

[ Price : $8.95]

Federal Register notice: FDA announces that 23 information collections have been approved by OMB.

Teva Shuts Plant, Recalls Drugs Over Sterility

[ Price : $8.95]

Teva Pharmaceuticals temporarily stops production at its Irvine, CA manufacturing facility after a recent FDA inspection cited man...

Communicating Cybersecurity Best Practices

[ Price : $8.95]

FDA posts a document entitled Best Practices for Communicating Cybersecurity Vulnerabilities to Patients.

Comments Extended on FDA Genus Notice

[ Price : $8.95]

Federal Register notice: FDA extends the comment period for the notice entitled Genus Medical Technologies LLC Versus Food and Dru...

Guide on Studying Multiple Gene Therapies

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Studying Multiple Versions of a Cellular or Gene Therapy Pr...